Search results
Alex Jones' Robert De Niro message takes off online
Newsweek· 5 days agoThe conservative commentator slammed De Niro's recent Trump comments, calling the 80-year-old a "clear and present danger to our Republic."
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Medical Xpress· 4 days agoThe virus's exceptional ability to change and evade immune defenses has led the World Health...
Keeping Up With COVID Vaccines Arms The Immune System Against Future Variants And Viruses
IFLScience· 2 days agoKeeping up with your COVID vaccines could have benefits beyond just topping up immunity to the...
Genetics Played a Role in Blood Clots Linked to COVID-19 Shots
Time Magazine· 6 days agoRare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 shots were...
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 7 days agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
A boost for HIV vaccine research: Studies present comprehensive platform for validating next steps
Medical Xpress· 13 hours agoA substantial amount of research has demonstrated the feasibility of the initial activation step; now, in two papers simultaneously out in Science and Science Immunology, researchers at the ...
Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
TipRanks via Yahoo Finance· 4 days agoModerna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again...
Robeco Institutional Asset Management B.V. Decreases Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 20 hours agoRobeco Institutional Asset Management B.V. lowered its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 51.1% in the 4th quarter, according to the company in its most ...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 5 days agoBoth companies will still have the right to create their own combined COVID-19-influenza combination...
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Pharmaceutical Technology via Yahoo Finance· 7 days agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...